Sunday, June 16, 2024

Zevra Therapeutics GAAP EPS of -$0.40 beats by $0.08, revenue of $3.42M misses by $0.34M

Must read

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.

Is this happening to you frequently? Please

report it on our feedback forum.

If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.

More articles

Latest article